Green Cross says adjuvant promising in new flu vaccine
Published: 2009-11-09 07:00:00
Updated: 2009-11-09 07:00:00
Green Cross Corporation, a local drug maker responsible for the domestic production of the flu vaccine, said that its new vaccine with an adjuvant demonstrated excellent antibody-producing effects against the H1N1 flu virus in animal experiments.
Led by Professor Choi Young-gi of Chungbuk Univ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
